205 related articles for article (PubMed ID: 34246170)
21. Network pharmacology and metabolomics study on the intervention of traditional Chinese medicine Huanglian Decoction in rats with type 2 diabetes mellitus.
Pan L; Li Z; Wang Y; Zhang B; Liu G; Liu J
J Ethnopharmacol; 2020 Aug; 258():112842. PubMed ID: 32333952
[TBL] [Abstract][Full Text] [Related]
22. Urine and plasma metabolomics study on potential hepatoxic biomarkers identification in rats induced by Gynura segetum.
Qiu S; Zhang H; Fei Q; Zhu F; Wang J; Jia X; Chen B
J Ethnopharmacol; 2018 Apr; 216():37-46. PubMed ID: 29353003
[TBL] [Abstract][Full Text] [Related]
23. [Determination of complexation ability of rhubarb with copper ions by ultra-high performance liquid chromatography].
Liu YP; Zhang W; Liu XJ; Wu H; Zhou A
Se Pu; 2023 Apr; 41(4):323-329. PubMed ID: 37005919
[TBL] [Abstract][Full Text] [Related]
24. Characterizing metabolites and potential metabolic pathways changes to understanding the mechanism of medicinal plant Phellodendri Amurensis cortex against doxorubicin-induced nephritis rats using UPLC-Q/TOF-MS metabolomics.
Zhang H; Zhang S; Wang W; Wang Q; Kuang H; Wang Q
J Pharm Biomed Anal; 2020 Sep; 188():113336. PubMed ID: 32653762
[TBL] [Abstract][Full Text] [Related]
25. Metabolic profiling of chronic obstructive pulmonary disease model rats and the interventional effects of HuaTanJiangQi decoction using UHPLC-Q-TOF/MS
Fang W; Li C; Wu Q; Yao Z; Wu J; Huang P; Wang D; Li Z
J Pharm Biomed Anal; 2020 Feb; 180():113078. PubMed ID: 31911286
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the mechanism of Danggui-Shaoyao-San in regulating the metabolome of nephrotic syndrome based on urinary metabonomics and bioinformatics approaches.
Wang Y; Fan S; Yang M; Shi G; Hu S; Yin D; Zhang Y; Xu F
J Ethnopharmacol; 2020 Oct; 261():113020. PubMed ID: 32592886
[TBL] [Abstract][Full Text] [Related]
27. Nontargeted urine metabolomics analysis of the protective and therapeutic effects of Citri Reticulatae Chachiensis Pericarpium on high-fat feed-induced hyperlipidemia in rats.
Zeng W; Huang KE; Luo Y; Li DX; Chen W; Yu XQ; Ke XH
Biomed Chromatogr; 2020 Apr; 34(4):e4795. PubMed ID: 31967660
[TBL] [Abstract][Full Text] [Related]
28. LC-MS based urinary metabolomics study of the intervention effect of aloe-emodin on hyperlipidemia rats.
Ji H; Liu Y; He F; An R; Du Z
J Pharm Biomed Anal; 2018 Jul; 156():104-115. PubMed ID: 29698861
[TBL] [Abstract][Full Text] [Related]
29. Metabonomics study on the effect of Siwu Decoction for blood deficiency syndrome in rats using UPLC-Q/TOF-MS analysis.
He Y; Gao T; Li J; Chen Z; Wang L; Zhang J; Gao F; Fu C
Biomed Chromatogr; 2019 Nov; 33(11):e4617. PubMed ID: 31207665
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the Hepatotoxicity of the Zhi-Zi-Hou-Po Decoction by Combining UPLC-Q-Exactive-MS-Based Metabolomics and HPLC-MS/MS-Based Geniposide Tissue Distribution.
Wang Y; Feng F
Molecules; 2019 Jan; 24(3):. PubMed ID: 30708983
[TBL] [Abstract][Full Text] [Related]
31. Untargeted metabolomics reveal the therapeutic effects of Ermiao wan categorized formulas on rats with hyperuricemia.
Shan B; Chen T; Huang B; Liu Y; Chen J
J Ethnopharmacol; 2021 Dec; 281():114545. PubMed ID: 34419610
[TBL] [Abstract][Full Text] [Related]
32. A plasma metabonomics study on the therapeutic effects of the Si-miao-yong-an decoction in hyperlipidemic rats.
Shi S; Liu Z; Xue Z; Chen X; Chu Y
J Ethnopharmacol; 2020 Jun; 256():112780. PubMed ID: 32222575
[TBL] [Abstract][Full Text] [Related]
33. [Liquid chromatography-mass spectrometry-based metabolomics study of the efficacy of Chinese medicine asthma-relieving decoction on respiratory syncytial virus infection].
Ouyang Y; Chi L; Xu C; Zhao X; Cui Z
Se Pu; 2021 Mar; 39(3):281-290. PubMed ID: 34227309
[TBL] [Abstract][Full Text] [Related]
34. UPLC/Q-TOF-MS/MS-based metabolomics revealed the lipid-lowering effect of Ilicis Rotundae Cortex on high-fat diet induced hyperlipidemia rats.
Yang B; Xuan S; Ruan Q; Jiang S; Cui H; Zhu L; Luo X; Jin J; Zhao Z
J Ethnopharmacol; 2020 Jun; 256():112784. PubMed ID: 32222573
[TBL] [Abstract][Full Text] [Related]
35. Serum and urine metabolomics based on UPLC-Q-TOF/MS reveals the antipyretic mechanism of Reduning injection in a rat model.
Gao X; Huang C; Geng T; Chen X; Wang J; Liu J; Duan K; Cao L; Wang Z; Xiao W
J Ethnopharmacol; 2020 Mar; 250():112429. PubMed ID: 31812644
[TBL] [Abstract][Full Text] [Related]
36. Metabolomic profiling for identification of potential biomarkers in the protective effects of modified Sinisan against liver injury in dimethylnitrosamine treated rats.
Liu CG; Wang XL; Du XW; Jiang DY; Geng NZ; Zhang SX; Zhou YY; Kuang HX
Biol Pharm Bull; 2013; 36(11):1700-7. PubMed ID: 24189414
[TBL] [Abstract][Full Text] [Related]
37. Effects of Tao-Hong-Si-Wu decoction on acute blood stasis in rats based on a LC-Q/TOF-MS metabolomics and network approach.
Ma Q; Li PL; Hua YL; Ji P; Yao WL; Zhang XS; Zhong LJ; Wei YM
Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29149492
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of the compatibility effects of Danggui-Sini Decoction on a blood stasis syndrome rat model using untargeted metabolomics.
Wu JX; Zheng H; Yao X; Liu XW; Zhu HJ; Yin CL; Liu X; Mo YY; Huang HM; Cheng B; Wu F; Chen ZN; Song FM; Ruan JX; Zhang HY; Liu P; Liang YH; Song H; Guo HW; Su ZH
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():164-175. PubMed ID: 30594827
[TBL] [Abstract][Full Text] [Related]
39. Dynamic urinary metabolomics analysis based on UHPLC-Q-TOF/MS to investigate the potential biomarkers of blood stasis syndrome and the effects of Danggui Sini decoction.
Huang H; Wu J; Lu R; Liu X; Chin B; Zhu H; Yin C; Cheng B; Wu Z; Chen X; Liang Y; Song H; Zheng H; Guo H; Su Z
J Pharm Biomed Anal; 2020 Feb; 179():112986. PubMed ID: 31787459
[TBL] [Abstract][Full Text] [Related]
40. [Metabolomic study on urine of chronic inflammation rats treated with Buyang Huanwu Decoction based on UPLC-Q-TOF-MS].
You XY; Jiang L; Wang WF; Xu X; Zhang SW; Liu HN; Yan XJ; Nie P; Li BT; Xu GL
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5345-5355. PubMed ID: 38114124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
